RecruitingPhase 3NCT07667803
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
Sponsor: AstraZeneca
DuBois, PA · Newport, PA · Philadelphia, PA · +53 more sites
2 recruiting obesity studies with a site in Newport, PA.
Sponsor: AstraZeneca
DuBois, PA · Newport, PA · Philadelphia, PA · +53 more sites
Sponsor: Amgen
Newport, PA · +70 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.